Fundacion Para La Investigacion Biomedica Del Hospital Universitario Puerta De Hierro Majadahonda

5 trials 5 recruiting Academic / non-commercial

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

5 Recruiting

0 Completed trials

5 Countries active

5 Unique IMPs

N/A Results reported

Phase III

Phase II

Phase IV

Phase III: 2 Phase II: 1 Phase IV: 2

Top indications

Gene mutation 1

Top IMPs

ALLOGENEIC BONE MARROW-DERIVED MESENCHYMAL ADULT STROMAL CELLS, EX-VIVO EXPANDED 1 ALLOGENEIC BONE MARROW-DERIVED MESENCHYMAL STROMAL CELLS, FROM SELECTED DONORS 1 CANDESARTAN CILEXETIL 1 VALSARTAN, SACUBITRIL 1

All trials

5 total

A multi-centre, single-arm study to demonstrate the efficacy of bone marrow allogeneic mesenchymal cells combined with biomaterial (combined… Recruiting

2025-520841-60-00 Phase III 4 countries ALLOGENEIC BONE MARROW-DERIVED MESENCHYMAL STROMAL CELLS, FROM SELECTED DONORS
Effect of pharmacological treatment with angiotensin receptor/neprilysin inhibitors on transthyretin cardiac amyloidosis and heart failure w… Recruiting

2024-515661-34-00 Phase IV 1 country VALSARTAN, SACUBITRIL
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) versus Conventional Treatment in Acute Myocarditis: INFLAMA study Recruiting

2024-513803-15-00 Phase IV 1 country
AN OPEN LABEL, RANDOMISED, CONTROLLED CLINICAL TRIAL TO ASSESS THE SAFETY OF ENDOBRONCHIAL ADMINISTRATION OF ALLOGENEIC MESENCHYMAL STROMAL … Recruiting

2023-509341-12-00 Phase II 1 country ALLOGENEIC BONE MARROW-DERIVED MESENCHYMAL ADULT STROMAL CELLS, EX-VIVO EXPANDED
EARLY treatment with Candesartan vs Placebo in asymptomatic GENEtic carriers of Dilated Cardiomyopathy (EARLY-GENE trial) Recruiting

2023-507029-40-00 Phase III 2 countries CANDESARTAN CILEXETIL

Showing 1–5 of 5 trials

← All sponsors A–Z